“It’s an honor to be recognized for our work in healthcare M&A from one of the industry’s leading platforms. At MAHA, our focus has always been on providing exemplary service to our clients and serving as a trusted advisor during the buy/sell process. We celebrate this recognition from Axial and we look forward to being the standard for excellence in Healthcare M&A for years to come.” Mike Moran, Partner & Executive Advisor, M&A Healthcare Advisors

The Top 50 Lower Middle Market Healthcare Investors & M&A Advisors [2022]

M&A Healthcare Advisors (MAHA) is proud to be named to Axial's Top 50 Lower Middle Market Healthcare Investors & M&A Advisors (2022). For the second year in a row, MAHA has been recognized as a leading M&A advisor by Axial, the largest platform on the internet for buying, selling, advising, and financing private companies.

Methodology
Axial’s Top 50 healthcare list was generated based on a weighted formula leveraging private transaction data from the Axial platform.

Metrics in the formula include:

  • the number of healthcare deals brought to market via Axial (sell-side)
  • the level of interest those deals generated from Axial’s buy-side member base
  • the number of specific healthcare-focused investment mandates created in the platform (buy-side)
  • the number of healthcare deals that progressed through the deal funnel achieving an executed LOI or successfully consummated transaction (buy-side & sell-side).